心力衰竭的早期息护理显示了EF亚型的中性效应:一个探索性的EPCHF二次分析
Mahmoud Balata1, Asim Khan2, Marwa Hassan3
1Department of Cardiology, University Hospital of Rostock, Ernst-Heydemann-Straße 6, 18057, Rostock, Germany. Mahmoud.Balata.MD@gmail.com.
概括
早期的息治疗整合并没有改善心力衰竭患者的整体生活质量. 然而,它显著增强了那些保持喷射分数 (LVEF> 40%) 的精神健康.
科学领域:
- 心脏病学 心脏病学
- 抚慰性护理是一种缓解性护理.
- 健康 结果 研究 研究 结果
背景情况:
- 缓和护理的早期整合 (EIPC) 旨在改善心力衰竭 (HF) 的生活质量 (QOL).
- 证据表明EIPC在HF中的有效性是混合的,其对不同HF亚型的影响仍然不清楚.
- 这项研究探讨了EIPC的效果,以左心室喷射率 (LVEF) 分层.
研究的目的:
- 调查EIPC对心力衰竭 (HF) 患者报告结果的影响.
- 为了确定EIPC的效果是否不同,HF患者减少喷射分数 (HFrEF) 和保存喷射分数 (HFpEF).
主要方法:
- 对EPCHF试验的探索性二次分析,涉及205名具有症状的HF患者,随机分配到EIPC或标准护理.
- 患者根据LVEF (≤40%vs>40%) 进行了分层分析.
- 患者报告的结果在12个月内使用验证的问卷进行评估,包括KCCQ,FACIT-PAL,HADS,MIDOS和FACIT-SP12.
主要成果:
- 与标准护理相比,EIPC在LVEF亚组中没有显著改善整体QOL,情绪或症状负担.
- 在EIPC和对照组中观察到抑郁症状的显著减少,对于HFrEF患者 (LVEF ≤40%).
- 与标准治疗相比,EIPC显著改善了HFpEF (LVEF>40%) 患者的精神健康,对照组没有改善.
结论:
- 在HF患者中,EIPC没有证明QOL,情绪或症状的整体益处.
- 一个值得注意的发现是,接受EIPC的HF患者的精神健康状况有所改善,HF患者的喷射分数保存 (LVEF>40%) 得到了改善.
- 这表明HFpEF患者可能有特定的支持性护理需求,需要进一步调查.
相关概念视频
01:17Pathophysiology of Heart Failure
2.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
01:30Heart Failure V: Medical Management
195
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
195
01:29Heart Failure II: Pathophysiology
658
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
658
01:30Heart Failure IV: Classification and Diagnostic Evaluation
281
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
281
01:30Heart Failure VII: Nursing Interventions
389
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
389
01:30Cardiomyopathy II: Dilated Cardiomyopathy
427
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
427